Peter B. Corr, PhD, is Executive Chairman of the Board of Directors of Imvax, Inc., as well as Co-Founder and Managing General Partner of Auven Therapeutics Management. He retired from Pfizer Inc. in December 2006, where he was Senior Vice President for Science and Technology.
Previously, Dr. Corr served as Executive Vice President, Pfizer Global Research & Development, and Senior Vice President, Discovery Research, at Monsanto/Searle and then as President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis. He spent 18 years at Washington University in St. Louis as Professor, Department of Medicine (Cardiology) and Department of Pharmacology and Molecular Biology.
Dr. Corr is the Chairman of the Board of Directors of ADC Therapeutics and Chairman of the Board of Patient Assist VI which provides medicines to indigent patients in the US Virgin Islands. He has held a number of Chairmanships, including the Science & Regulatory Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA).